Availability of results from clinical research: Failing policy efforts

被引：17
作者：
Shamliyan T.A. [1 ,2 ,3 ]
Kane R.L. [1 ,2 ]
机构：
[1] Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN
[2] Minnesota Evidence-based Practice Center, Minneapolis, MN
[3] Elsevier Clinical Solutions, Evidence-Based Medicine Center
来源：
Journal of Epidemiology and Global Health | 2014年 / 4卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Clinical epidemiology; Clinical research Standards; Evidence based medicine; Publication bias;
D O I：
10.1016/j.jegh.2013.08.002
中图分类号：
学科分类号：
摘要：
Objectives: Trial registration has a great potential to increase research transparency and public access to research results. This study examined the availability of results either in journal publications or in the trial registry from all studies registered at ClinicalTrials.gov. Methods: All 137,612 records from ClinicalTrials.gov in December 2012 were merged with all 19,158 PubMed records containing registration numbers in the indexing field or in the abstracts. A multivariate analysis was conducted to examine the association between the availability of the results with study and participant characteristics available in registration records. Results: Fewer than 10% of the registered studies and 15% of the registered and completed studies had published results. The highest publication rate of 22.4% was for randomized trials completed between 2005 (starting year for structured indexing in PubMed of study registration) and 2010. For 86% of overall and 78% of completed registered studies, no results were available in ClinicalTrials.gov or in journal publications. Studies funded by industry vs. other funding sources and drug studies vs. all studies of other interventions were published less often after adjustment for study type, subject characteristics, or posting of results in ClinicalTrials.gov. Conclusion: Existing policy does not ensure availability of results from clinical research. International policy revisions should charge principal investigators with ensuring that the approved protocols and posted data elements are aligned and that results are available from all conducted studies. © 2013 Ministry of Health, Saudi Arabia.
引用
收藏
页码：1 / 12
页数：11
相关论文
共 39 条
  • [1] Clancy C.M., Slutsky J.R., Patton L.T., Evidence-based health care 2004: AHRQ moves research to translation and implementation, Health Serv Res, 39, 5, (2004)
  • [2] Kaiser J.U.S., Budget 2009. NIH hopes for more mileage from roadmap, Science, 319, 5864, (2008)
  • [3] Loscalzo J., The N.I.H. budget and the future of biomedical research, N Engl J Med, 354, 16, pp. 1665-1667, (2006)
  • [4] Steinbrook R., The N.I.H. stimulus - the recovery act and biomedical research, N Engl J Med, 360, 15, pp. 1479-1481, (2009)
  • [5] Slutsky J.R., Clancy C.M., The Agency for Healthcare Research and Quality's Effective Health Care Program: creating a dynamic system for discovering and reporting what works in health care, Am J Med Qual, 20, 6, pp. 358-360, (2005)
  • [6] Hopewell S., Loudon K., Clarke M.J., Oxman A.D., Dickersin K., Publication bias in clinical trials due to statistical significance or direction of trial results, Cochrane Database Syst Rev, 1, (2009)
  • [7] Dickersin K., The existence of publication bias and risk factors for its occurrence, JAMA, 263, 10, pp. 1385-1389, (1990)
  • [8] Dickersin K., How important is publication bias? A synthesis of available data, AIDS Educ Prev, 9, SUPPL. 1, pp. 15-21, (1997)
  • [9] Dickersin K., Min Y.I., Publication bias: the problem that won't go away, Ann N Y Acad Sci, 703, pp. 135-146, (1993)
  • [10] Ioannidis J.P., Why most published research findings are false: author's reply to Goodman and Greenland, PLoS Med, 4, 6, (2007)
1234